PROGRAM PLANNING AND EVALUATIONThe Cancer Center has benefited from broad participation of the membership in its planning andimplementation process. In addition, it has taken advantage of formal and ad hoc consultations that havehad a major impact on program development. The leadership intends to continue to receive outsideconsultation, as well as advice from within the institution as it goes forward.External Scientific Advisory BoardThe development of the Cancer Center has been to a large extent guided by the advice of the ExternalScientific Advisory Board, which has convened on two occasions (March, 2004 and May, 2005) on theStanford campus to comment on progress in the recruitment of the senior leadership and to evaluate theresearch programs and shared resources. This Board is constituted of highly experienced scientists,administrators and leaders from the cancer research community, all of whom have considerableexpertise in the planning and evaluation of NCI-designated Comprehensive Cancer Centers. Their inputhas been invaluable and has continued to the time of submission of this proposal with consultationsthrough telephone and e-mail. This Board will provide an ongoing source of consultation to theleadership as it evaluates its current activities and develops new initiatives.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA124435-01
Application #
7438412
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-06-04
Project End
2010-05-31
Budget Start
2007-06-04
Budget End
2008-05-31
Support Year
1
Fiscal Year
2007
Total Cost
$118,751
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Patel, Manali I; Sundaram, Vandana; Desai, Manisha et al. (2018) Effect of a Lay Health Worker Intervention on Goals-of-Care Documentation and on Health Care Use, Costs, and Satisfaction Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol 4:1359-1366
Trieu, Vanessa; Pinto, Harlan; Riess, Jonathan W et al. (2018) Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck. Oncologist 23:764-e86
Kuonen, François; Surbeck, Isabelle; Sarin, Kavita Y et al. (2018) TGF?, Fibronectin and Integrin ?5?1 Promote Invasion in Basal Cell Carcinoma. J Invest Dermatol 138:2432-2442
Gee, Marvin H; Han, Arnold; Lofgren, Shane M et al. (2018) Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes. Cell 172:549-563.e16
Malta, Tathiane M; Sokolov, Artem; Gentles, Andrew J et al. (2018) Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell 173:338-354.e15
Banerjee, Imon; Gensheimer, Michael Francis; Wood, Douglas J et al. (2018) Probabilistic Prognostic Estimates of Survival in Metastatic Cancer Patients (PPES-Met) Utilizing Free-Text Clinical Narratives. Sci Rep 8:10037
Thorsson, Vésteinn; Gibbs, David L; Brown, Scott D et al. (2018) The Immune Landscape of Cancer. Immunity 48:812-830.e14
Rogers, Zoë N; McFarland, Christopher D; Winters, Ian P et al. (2018) Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice. Nat Genet 50:483-486
Nair, Viswam S; Sundaram, Vandana; Desai, Manisha et al. (2018) Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial. Am J Respir Crit Care Med 197:1220-1223
She, Richard; Jarosz, Daniel F (2018) Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change. Cell 172:478-490.e15

Showing the most recent 10 out of 322 publications